A New Dimension to Ras Function: A Novel Role for Nucleotide-Free Ras in Class II Phosphatidylinositol 3-Kinase Beta (PI3KC2β) Regulation

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wong, Katy A ^a   Russo, Angela ^a   Wang, Xuerong ^a   Chen, Yun Ju ^a   Lavie, Arnon ^a   O'Bryan, John P ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; ASPARTIC ACID; GUANOSINE TRIPHOSPHATE; LYSINE; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE BETA CLASS 2; PROTEIN KINASE B; RAS PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CLASS II PHOSPHATIDYLINOSITOL 3-KINASES; COS CELLS; HUMANS; POINT MUTATION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RAS PROTEINS;

EID: 84866375875     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045360     Document Type: Article

References (45)

1. Karnoub AE, Weinberg RA, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
2. Zhang Z, Wang Y, Vikis HG, Johnson L, Liu G, et al. (2001) Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 29: 25-33.
3. Spandidos A, Wilkie NM (1988) The normal human H-ras1 gene can act as an onco-suppressor. Br J Cancer Suppl 9: 67-71.
4. Spandidos DA, Frame M, Wilkie NM, (1990) Expression of the normal H-ras1 gene can suppress the transformed and tumorigenic phenotypes induced by mutant ras genes. Anticancer Res 10: 1543-1554.
5. Diaz R, Ahn D, Lopez-Barcons L, Malumbres M, Perez de Castro I, et al. (2002) The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. Cancer Res 62: 4514-4518.
6. Takeuchi S, Mori N, Koike M, Slater J, Park S, et al. (1996) Frequent loss of heterozygosity in region of the KIP1 locus in non-small cell lung cancer: evidence for a new tumor suppressor gene on the short arm of chromosome 12. Cancer Res 56: 738-740.
7. De Gregorio L, Manenti G, Incarbone M, Pilotti S, Pastorino U, et al. (1998) Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinoma. Int J Cancer 79: 269-272.
8. Kibel AS, Schutte M, Kern SE, Isaacs WB, Bova GS, (1998) Identification of 12p as a region of frequent deletion in advanced prostate cancer. Cancer Res 58: 5652-5655.
9. Feig LA, (1999) Tools of the trade: use of dominant-inhibitory mutants of Ras-family GTPases. Nat Cell Biol 1: E25-27.
10. Feig LA, Cooper GM, (1988) Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP. Mol Cell Biol 8: 3235-3243.
11. Quilliam LA, Hisaka MM, Zhong S, Lowry A, Mosteller RD, et al. (1996) Involvement of the switch 2 domain of Ras in its interaction with guanine nucleotide exchange factors. J Biol Chem 271: 11076-11082.
12. Stewart S, Guan KL, (2000) The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation. J Biol Chem 275: 8854-8862.
13. O'Bryan JP, (2010) INTERSECTINg Pathways in Cell Biology. Sci Signal 3: re10.
14. Guipponi M, Scott HS, Hattori M, Ishii K, Sakaki Y, et al. (1998) Genomic structure, sequence, and refined mapping of the human intersectin gene (ITSN), which encompasses 250 kb on chromosome 21q22.1- >q22.2. Cytogenet Cell Genet 83: 218-220.
15. Yamabhai M, Hoffman NG, Hardison NL, McPherson PS, Castagnoli L, et al. (1998) Intersectin, a novel adaptor protein with two Eps15 homology and five Src homology 3 domains. J Biol Chem 273: 31401-31407.
16. Sengar AS, Wang W, Bishay J, Cohen S, Egan SE, (1999) The EH and SH3 domain Ese proteins regulate endocytosis by linking to dynamin and Eps15. EMBO J 18: 1159-1171.
17. Okamoto M, Schoch S, Sudhof TC, (1999) EHSH1/intersectin, a protein that contains EH and SH3 domains and binds to dynamin and SNAP-25. A protein connection between exocytosis and endocytosis? J Biol Chem 274: 18446-18454.
18. Hussain NK, Yamabhai M, Ramjaun AR, Guy AM, Baranes D, et al. (1999) Splice variants of intersectin are components of the endocytic machinery in neurons and nonneuronal cells. J Biol Chem 274: 15671-15677.
19. Chabu C, Doe CQ, (2008) Dap160/intersectin binds and activates aPKC to regulate cell polarity and cell cycle progression. Development 135: 2739-2746.
20. He G, Wang HR, Huang SK, Huang CL, (2007) Intersectin links WNK kinases to endocytosis of ROMK1. J Clin Invest 117: 1078-1087.
21. Martin NP, Mohney RP, Dunn S, Das M, Scappini E, et al. (2006) Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling. Mol Pharmacol 70: 1643-1653.
22. Das M, Scappini E, Martin NP, Wong KA, Dunn S, et al. (2007) Regulation of neuron survival through an intersectin-phosphoinositide 3′-kinase C2beta-AKT pathway. Mol Cell Biol 27: 7906-7917.
23. Adams A, Thorn JM, Yamabhai M, Kay BK, O'Bryan JP, (2000) Intersectin, an adaptor protein involved in clathrin-mediated endocytosis, activates mitogenic signaling pathways. J Biol Chem 275: 27414-27420.
24. Mohney RP, Das M, Bivona TG, Hanes R, Adams AG, et al. (2003) Intersectin activates Ras but stimulates transcription through an independent pathway involving JNK. J Biol Chem 278: 47038-47045.
25. Wong KA, O'Bryan JP (2011) Bimolecular Fluorescence Complementation. J Vis Exp: e2643.
26. Arcaro A, Volinia S, Zvelebil MJ, Stein R, Watton SJ, et al. (1998) Human phosphoinositide 3-kinase C2beta, the role of calcium and the C2 domain in enzyme activity. J Biol Chem 273: 33082-33090.
27. Shyu YJ, Hiatt SM, Duren HM, Ellis RE, Kerppola TK, et al. (2008) Visualization of protein interactions in living Caenorhabditis elegans using bimolecular fluorescence complementation analysis. Nat Protoc 3: 588-596.
28. Kerppola TK, (2006) Visualization of molecular interactions by fluorescence complementation. Nat Rev Mol Cell Biol 7: 449-456.
29. Tong XK, Hussain NK, de Heuvel E, Kurakin A, Abi-Jaoude E, et al. (2000) The endocytic protein intersectin is a major binding partner for the Ras exchange factor mSos1 in rat brain. EMBO J 19: 1263-1271.
30. Vojtek AB, Hollenberg SM, Cooper JA, (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214.
31. Lai CC, Boguski M, Broek D, Powers S, (1993) Influence of guanine nucleotides on complex formation between Ras and CDC25 proteins. Mol Cell Biol 13: 1345-1352.
32. White MA, Nicolette C, Minden A, Polverino A, Van Aelst L, et al. (1995) Multiple Ras functions can contribute to mammalian cell transformation. Cell 80: 533-541.
33. Gupta S, Ramjaun AR, Haiko P, Wang Y, Warne PH, et al. (2007) Binding of Ras to Phosphoinositide 3-Kinase p110alpha Is Required for Ras- Driven Tumorigenesis in Mice. Cell 129: 957-968.
34. Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, et al. (2000) Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103: 931-943.
35. Smith MR, DeGudicibus SJ, Stacey DW, (19Requirement for c-ras proteins during viral oncogene transformation. Nature 320: 540-543.
36. Bourne HR, Sanders DA, McCormick F, (1990) The GTPase superfamily: a conserved switch for diverse cell functions. Nature 348: 125-132.
37. Proud CG, (1986) Guanine nucleotides, protein phosphorylation and the control of translation. Trends in Biochemical Sciences 11: 73-77.
38. Mor A, Philips MR, (2006) Compartmentalized Ras/MAPK signaling. Annu Rev Immunol 24: 771-800.
39. Russo A, O'Bryan JP (2012) Intersectin 1 is required for neuroblastoma tumorigenesis. Oncogene.
40. Ponting CP, Benjamin DR, (1996) A novel family of Ras-binding domains. Trends Biochem Sci 21: 422-425.
41. Wohlgemuth S, Kiel C, Kramer A, Serrano L, Wittinghofer F, et al. (2005) Recognizing and defining true Ras binding domains I: biochemical analysis. J Mol Biol 348: 741-758.
42. Kalhammer G, Bahler M, Schmitz F, Jockel J, Block C, (1997) Ras-binding domains: predicting function versus folding. FEBS Lett 414: 599-602.
43. Rodriguez-Viciana P, Sabatier C, McCormick F, (2004) Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 24: 4943-4954.
44. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, et al. (2006) PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 21: 481-493.
45. Lu A, Tebar F, Alvarez-Moya B, Lopez-Alcala C, Calvo M, et al. (2009) A clathrin-dependent pathway leads to KRas signaling on late endosomes en route to lysosomes. J Cell Biol 184: 863-879.